Illumina | ILMN - Net Income


Illumina reported $334M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Agilent USD 305M 129M Dec/2025
Bio Techne USD 38.01M 176K Dec/2025
Bio-Rad Laboratories USD -341.9M 659.7M Sep/2025
Boston Scientific USD 672M 83M Dec/2025
Bruker USD 26M 88.4M Dec/2025
Charles River Laboratories USD -276.56M 330.98M Dec/2025
Danaher USD 1.2B 289M Dec/2025
Dentsply International USD -146M 281M Dec/2025
Edwards Lifesciences USD 91.2M 199.9M Dec/2025
Hologic USD 179.1M 8.2M Dec/2025
Illumina USD 334M 184M Dec/2025
Intuitive Surgical USD 794.8M 90.4M Dec/2025
IQVIA Holdings USD 514M 183M Dec/2025
Laboratory Of America USD 164.7M 96.4M Dec/2025
Mettler Toledo International USD 285.76M 68.27M Dec/2025
Myriad Genetics USD -7.9M 19.5M Dec/2025
OraSure Technologies USD -19.29M 5.57M Dec/2025
Pacific Biosciences Of California USD -40.37M 2.37M Dec/2025
Quest Diagnostics USD 245M 0 Dec/2025
Quidel USD -733M 477.6M Sep/2025
Repligen USD 13.29M 1.62M Dec/2025
Revvity USD 98.36M 51.71M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Standard Biotools USD 19.28M 53.97M Dec/2025
Thermo Fisher Scientific USD 1.96B 348M Dec/2025
Waters USD 225.21M 76.29M Dec/2025